LAPTM4B and metastatic malignant neoplasm in the lymph nodes: Serum LAPTM4B levels of LAC patients were significantly correlated with smoking, advanced clinical stages, lymph node metastasis, anaplastic lymphoma kinase (ALK) rearrangements and EGFR mutations.